文献速递妇科生殖医学

子宫内膜异位囊肿乙醇硬化治疗后的卵巢储备与IVF结局:系统综述与Meta分析

Ovarian reserve and IVF outcomes after ethanol ovarian sclerotherapy in women with endometrioma: a systematic review and meta-analysis.
PubMed 文献 · Reprod Biomed Online · 2025-02-16

该系统综述与Meta分析纳入28项研究共1877例患者,比较乙醇硬化治疗与囊肿剥除术对子宫内膜异位囊肿患者卵巢储备及IVF结局的影响。结果显示硬化治疗组抗苗勒管激素浓度变化更小,临床妊娠率更高,获卵总数、MII卵母细胞数及胚胎数更多;受精率与促性腺激素剂量差异无统计学意义。作者认为硬化治疗可作为有生育需求、尤其卵巢储备低下患者的可行治疗选择。

要点

  • 乙醇硬化治疗较囊肿剥除术更好地保留卵巢储备,抗苗勒管激素浓度变化更小。
  • 硬化治疗组IVF临床妊娠率更高,获卵总数、MII卵母细胞数及胚胎数更多。
  • 两组受精率与促性腺激素剂量差异无统计学意义。

核心结论

  • 作者认为硬化治疗应被视为子宫内膜异位囊肿患者的可行治疗选择,尤其适用于卵巢储备低下且担忧未来生育力的女性。
  • 该治疗似乎具有保护卵巢功能与改善治疗后生育结局的双重获益。

研究设计与样本

  • 系统综述与Meta分析,系统检索PubMed、Embase、Scopus、Google Scholar、Medline、ClinicalTrials.gov及Cochrane对照试验中心注册库。
  • 检索关键词为「sclerotherapy and endometrioma」「cystectomy and endometrioma」及「sclerotherapy」。
  • 共纳入28项研究、1877例患者。

主要发现

  • 与囊肿剥除术相比,硬化治疗显著保留卵巢储备,表现为抗苗勒管激素浓度变化更小。
  • IVF结局有利于硬化治疗,临床妊娠率更高,获卵总数、MII卵母细胞数及胚胎数更多。
  • 受精率与促性腺激素剂量的差异无统计学意义。

临床怎么用

  • 作者认为硬化治疗应被视为子宫内膜异位囊肿患者的可行治疗选择,尤其适用于卵巢储备低下且担忧未来生育力的女性。
  • 该治疗似乎具有保护卵巢功能与改善治疗后生育结局的双重获益。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Sclerotherapy has emerged as a promising treatment for endometrioma, a gynaecological condition characterized by high recurrence and significant impacts on fertility. Unlike traditional surgery, sclerotherapy offers the advantage of preserving ovarian reserve; however, limited data exist regarding its effects on women of reproductive age undergoing IVF. This study compared ovarian reserve and IVF outcomes between ethanol-only sclerotherapy and cystectomy for endometrioma. A systematic search PubMed, Embase, Scopus, Google Scholar, Medline, ClinicalTrials.gov and the Cochrane Central register of controlled trials was conducted using the keywords 'sclerotherapy and endometrioma', 'cystectomy and endometrioma' and 'sclerotherapy'. A total of 28 studies involving 1877 patients were included in the analysis, demonstrating that sclerotherapy significantly preserved ovarian reserve, as evidenced by a smaller change in anti-Müllerian hormone concentrations compared with cystectomy. Additionally, IVF outcomes favoured sclerotherapy, with higher clinical pregnancy rates and an increased number of total oocytes, metaphase II oocytes and embryos. However, the differences in fertilization rates and gonadotrophin dosage were not significant. Based on these findings, sclerotherapy should be considered as a viable treatment option for women with endometrioma, particularly for those with low ovarian reserve who are concerned about their future fertility. This treatment appears to offer the dual benefits of preserving ovarian function and enhancing fertility outcomes after treatment.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Lavadia CMM, Jeong HG, Ryu KJ, et al. Ovarian reserve and IVF outcomes after ethanol ovarian sclerotherapy in women with endometrioma: a systematic review and meta-analysis. Reprod Biomed Online. 2025. PMID: 40440796. doi:10.1016/j.rbmo.2025.104840

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。